Loading stock data…
$5.87-0.13 (-2.17%)
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
Anteris Technologies Global Corp. in the Healthcare sector is trading at $5.87 with a market capitalization of $814M. Wall Street consensus targets $14.00 (4 analysts), implying a +138.5% move over the next 12 months. The stock is currently 47% below its 52-week high of $11.05, remaining 20.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.01M↑ | $494,000↑ | $310,000↓ | $429,000↓ | $618,000 |
| Gross Profit | $776,000↑ | $380,000↑ | $219,000↓ | $306,000↓ | $470,000 |
| Operating Income | -$31.00M↓ | -$24.01M↑ | -$29.21M↓ | -$22.27M↓ | -$20.88M |
| Net Income | -$29.09M↓ | -$23.02M↑ | -$29.20M↓ | -$22.24M↓ | -$20.83M |
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for...